ACE inhibition and glucose transport in insulin-resistant muscle: Roles of bradykinin and nitric oxide

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 277, Issue 1 46-1, 1999, Pages

  Henriksen, Erik J ^a   Jacob, Stephan ^b,c   Kinnick, Tyson R ^a   Youngblood, Erik B ^a   Schmit, Melanie B ^a   Dietze, Guenther J ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Max Grundig Clinic   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

2 deoxyglucose uptake; Epitrochlearis muscle; Obese Zucker rat

Indexed keywords

BRADYKININ; CAPTOPRIL; EPROSARTAN; INSULIN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; GLUCOSE TRANSPORT; INSULIN METABOLISM; INSULIN RESISTANCE; MUSCLE METABOLISM; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

EID: 0032767731     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.277.1.r332     Document Type: Article

References (32)

1. Balon, T. W., and J. L. Nadler. Nitric oxide is present from incubated skeletal muscle. J. Appl. Physiol. 77: 2519-2521, 1994.
2. Balon, T. W., and J. L. Nadler. Evidence that nitric oxide increases glucose transport in skeletal muscle. J. Appl. Physiol. 82: 359-363, 1997.
3. Baron, A. D. The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes 45: S105-S109, 1996.
4. Carvalho, C. R. O., A. C. P. Thirone, J. A. R. Gontijo, L. A. Velloso, and M. J. A. Saad. Effect of captopril, losartan, and bradykinin on early steps of insulin action. Diabetes 46: 1950-1957, 1997.
5. Cheatham, B., and C. R. Kahn. Insulin action and the insulin signaling network. Endocr. Rev. 16:117-142, 1995.
6. DeFronzo, R. A., and E. Ferrannini. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
7. Dietze, G. J. Modulation of the action of insulin in relation to the energy state in skeletal muscle tissue: possible involvement of kinins and prostaglandins. Mol. Cell. Endocrinol. 25: 127-169, 1982.
8. Dietze, G. J., M. Wicklmayr, K. Rett, S. Jacob, and E. J. Henriksen. Potential role of bradykinin in forearm muscle metabolism in humans. Diabetes 45: S110-S114, 1996.
9. Etgen, G. J., D. A. Fryburg, and E. M. Gibbs. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/ contraction- and phosphotidylinositol-3-kinase-independent pathway. Diabetes 46: 1915-1919, 1997.
10. 2 receptors on skeletal muscle cells. Diabetes 45: S24-S28, 1996.
11. Gulve, E. A, E. J. Henriksen, K. J. Rodnick, J. H. Youn, and J. O. Holloszy. Glucose transporters and glucose transport in skeletal muscles of 1-to 25-mo-old rats. Am. J. Physiol. 264 (Endocrinol. Metab. 27): E319-E327, 1993.
12. Hansen, P. A., E. A. Gulve, and J. O. Holloszy. Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J. Appl. Physiol. 76: 979-985, 1994.
13. Henriksen, E. J., and S. Jacob. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 44: 267-272, 1995.
14. Henriksen, E. J., S. Jacob, D. L. Fogt, and G. J. Dietze. Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance. Am. J. Physiol. 275 (Regulatory Integrative Comp. Physiol. 44): R40-R45, 1998.
15. Henriksen, E. J., and L. S. Ritter. Effect of soleus unweighting on stimulation of insulin-independent glucose transport activity. J. Appl. Physiol. 74: 1653-1657, 1993.
16. Jacob, S., E. J. Henriksen, D. L. Fogt, and G. J. Dietze. Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 45: 535-541, 1996.
17. Jauch, K. W., W. Hartl, B. Günther, M. Wichlmayr, K. Rett, and G. Dietze. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin dependent diabetes mellitus. Eur. J. Clin. Invest. 17: 448-454, 1987.
18. Kapur, S., S. Bedard, B. Marcotte, C. H. Cote, and A. Marette. Expression of nitric oxide synthase in skeletal muscle. A novel role for nitric oxide as a modulator of insulin action. Diabetes 46: 1691-1700, 1997.
19. Leighton, B., A. L. Sanderson, M. E. Young, G. K. Radda, E. A. Boehm, and J. F. Clark. Effects of treatment of spontaneously hypertensive rats with the angiotensin-converting enzyme inhibitor trandolapril and the calcium antagonist verapamil on the sensitivity of glucose metabolism to insulin in rat soleus muscle in vitro. Diabetes 45: S120-S124, 1996.
20. Mann, W. R., E. B. Villauer, D. Barilla, B. Battle, B. E. Dunning, and B. Balkan. Effects of bradykinin on glucose metabolism in isolated rat soleus muscle and on blood glucose levels in Ob/Ob mice (Abstract). Diabetes 44: 133A, 1995.
21. Mitchell, D., and K. Tyml. Nitric oxide release in rat skeletal muscle capillary. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H1696-H1703, 1996.
22. Miyata, T., T. Taguchi, M. Uehara, S. Isami, H. Kishikawa, K. Kaneko, E. Araki, and M. Shirichi. Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts. Eur. J. Endocrinol. 138: 344-352, 1998.
23. Paolisso, G., A. Gambardella, M. Verza, A. D'Amore, S. Sgambato, and M. Varricchio. ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients. J. Hum. Hypertens. 6: 175-179, 1992.
24. Pollare, T. Insulin sensitivity and blood lipids during antihypertensive treatment with special reference to ACE inhibition. J. Diabetes Complications 4: 75-78, 1990.
25. Roberts, C. K., R. J. Barnard, S. H. Scheck, and T. W. Balon. Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent. Am. J. Physiol. 273 (Endocrinol. Metab. 36): E220-E225, 1997.
26. Shen, W., M. S. Wolin, and T. H. Hintze. Defective endogenous nitric oxide-mediated modulation of cellular respiration in canine skeletal muscle after the development of heart failure. J. Heart Lung Transplant. 16: 1026-1034, 1997.
27. Torlone, E., A. M. Rambotti, G. Perriello, G. Botta, F. Santeusanio, P. Brunetti, and G. B. Bolli. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia 34: 119-125, 1991.
28. Uehara, M., H. Kishikawa, S. Isami, K. Kisanuki, Y. Ohkubo, N. Miyamura, T. Miyata, T. Yano, and M. Shichiri. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 37: 300-307, 1994.
29. Vuirinen-Markkola, H., and H. Yki-Järvinen. Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. Metabolism 44: 85-89, 1995.
30. Yang, H. Y. T., E. G. Erdös, and Y. Levin. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim. Biophys. Acta 214: 374-376, 1970.
31. Young, M. E., and B. Leighton. Evidence for altered sensitivity of the nitric oxide/cGMP signalling cascade in insulin-resistant skeletal muscle. Biochem. J. 329: 73-79, 1998.
32. Young, M. E., G. K. Radda, and B. Leighton. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem,. J. 322: 223-228, 1997.